Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-15

Clinical Trial Update: Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports ongoing Phase 1/2 evaluation of EcoActive for safety and efficacy in patients with inactive Crohn's disease; the study is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EcoActive

Snippet

Sponsor: Intralytix, Inc. | Conditions: Crohn Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING